Key facts
- This page summarizes Robert Chess's Form 4 filing for NEKTAR THERAPEUTICS (NKTR).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 14 Jun 2024, 18:02.
Robert Chess - 14 Jun 2024 Form 4 Insider Report for NEKTAR THERAPEUTICS (NKTR)
- Reporting relationship
- Director
- Issuer ticker
- NKTR
- Reported as of
- 14 Jun 2024
- Net transaction value
- -$23,400
- SEC form
- 4
- Accepted by SEC
- 14 Jun 2024, 18:02:51 UTC
- Prior SEC filing
- 09 Feb 2024
- Next SEC filing
- 13 Nov 2024
- Source filing
- View source filing
- Reporting owner signature
- Mark A. Wilson, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Chess filed Form 4 for NEKTAR THERAPEUTICS (NKTR) on 14 Jun 2024.
Change
- Previous filing in this sequence was filed on 09 Feb 2024.
- Current net transaction value: -$23,400.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NKTR
transaction
Common Stock
Sale
- Transaction value
- $23,400
- Shares
- -19,500
- Change %
- -7.1%
- Price
- $1.20
- Shares after
- 255,273
- Date
- 14 Jun 2024
- Ownership
- Direct
- Footnotes
- F1, F2
NKTR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,100
- Date
- 14 Jun 2024
- Ownership
- by daughter
- Footnotes
- F3
NKTR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,100
- Date
- 14 Jun 2024
- Ownership
- by son
- Footnotes
- F3
NKTR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,100
- Date
- 14 Jun 2024
- Ownership
- by daughter
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
This transaction was made pursuant to a Rule 10b5-1 trading plan.
Footnote F2
This transaction was executed in multiple trades at prices ranging from $1.19 to $1.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
Footnote F3
The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose.